BG Medicine, Inc. (BGMD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 11, 2025, 8:00 PM EDT
BG Medicine Market Cap
BG Medicine has a market cap or net worth of $1.14 thousand as of September 12, 2025. Its market cap has decreased by -99.79% in one year.
Market Cap
1.14K
Enterprise Value
n/a
Revenue
1.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 4, 2011, BG Medicine's market cap has decreased from 148.07M to 1.14K, a decrease of -100.00%. That is a compound annual growth rate of -55.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 1.14K | 10,236.36% |
| Dec 31, 2024 | 11.00 | -99.68% |
| Dec 30, 2022 | 3.41K | -99.57% |
| Dec 31, 2020 | 796.21K | 775.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |